William D. McClellan Jr.
Director, Apollo Endosurgery (United States).
Companies
- REATA PHARMACEUTICALS INCBoard member Mar 2, 2017 to Sep 26, 20231
- Apollo Endosurgery (United States)Board member Dec 29, 2016 to Apr 4, 20232
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Apollo Endosurgery (United States)0 shares3Apr 4, 2023- REATA PHARMACEUTICALS INC0 shares4Sep 26, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 26, 2023Returned to company 6,017 shares of REATA PHARMACEUTICALS INC4
- Jul 28, 2023Sold 5,000 shares at $164.49 of REATA PHARMACEUTICALS INC5
- Jul 28, 2023Converted 5,000 shares of REATA PHARMACEUTICALS INC5
- Jun 7, 2023Granted 1,682 shares at $93.61 of REATA PHARMACEUTICALS INC6
- Jun 7, 2023Granted 106 shares at $93.61 of REATA PHARMACEUTICALS INC6
- Apr 4, 2023Returned to company 2,000 shares of Apollo Endosurgery (United States)3
- Apr 4, 2023Returned to company 39,249 shares of Apollo Endosurgery (United States)3
- Jun 14, 2022Granted 14,224 shares of Apollo Endosurgery (United States)7
- Jun 8, 2022Granted 3,883 shares at $34.76 of REATA PHARMACEUTICALS INC8
- Jun 8, 2022Granted 287 shares at $34.76 of REATA PHARMACEUTICALS INC8
- Jan 3, 2022Granted 59 shares at $27.32 of REATA PHARMACEUTICALS INC9
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5SEC EDGARForm 4 filed Aug 1, 2023
- 6SEC EDGARForm 4 filed Jun 9, 2023
- 7SEC EDGARForm 4 filed Jun 16, 2022
- 8SEC EDGARForm 4 filed Jun 9, 2022
- 9SEC EDGARForm 4 filed Jan 5, 2022